Sanguine

Sanguine Biosciences is a pioneer of in-home specimen collection and a leader in direct-to-patient recruitment and digital health innovation. We partner with researchers on their study designs and support cross-sectional and longitudinal analyses with complex patient inclusion/exclusion sample collection criteria. Our growing community is made up of >30,000 medical record-verified, highly engaged, patient members, and >100 advocacy groups, allowing us to seamlessly work with the pharmaceutical industry to expedite and complete >600 pre-clinical and clinical condition-specific research studies to date. We’ve been cited in >80 scientific publications, including high-impact journals like Science, Blood, Science Advances, and Acta Neuropathologica, among others.